These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29956027)

  • 1. Prospective study of relevance of
    Alves Do Rego C; Namer IJ; Marcel C; Lefebvre F; Lagha-Boukbiza O; Renaud M; Tranchant C; Anheim M
    J Neurol; 2018 Sep; 265(9):2033-2039. PubMed ID: 29956027
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Yang T; Wang L; Li Y; Cheng M; Jiao J; Wang Q; Guo H
    J Neurol Sci; 2017 Feb; 373():48-51. PubMed ID: 28131225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
    Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
    Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating Parkinson's disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test.
    Kikuchi A; Baba T; Hasegawa T; Sugeno N; Konno M; Takeda A
    Parkinsonism Relat Disord; 2011 Nov; 17(9):698-700. PubMed ID: 21840242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis.
    Treglia G; Stefanelli A; Cason E; Cocciolillo F; Di Giuda D; Giordano A
    Clin Neurol Neurosurg; 2011 Dec; 113(10):823-9. PubMed ID: 21962800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy.
    Köllensperger M; Seppi K; Liener C; Boesch S; Heute D; Mair KJ; Mueller J; Sawires M; Scherfler C; Schocke MF; Donnemilier E; Virgolini I; Wenning GK; Poewe W
    Mov Disord; 2007 Sep; 22(12):1771-6. PubMed ID: 17579357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
    Pellecchia MT; Pivonello R; Salvatore E; Faggiano A; Barone P; De Michele G; Lombardi G; Colao A; Filla A
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal cardiac [(123)I]-meta-iodobenzylguanidine uptake in multiple system atrophy.
    Nagayama H; Ueda M; Yamazaki M; Nishiyama Y; Hamamoto M; Katayama Y
    Mov Disord; 2010 Aug; 25(11):1744-7. PubMed ID: 20645402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography.
    Lee EA; Kim BJ; Lee WY
    Mov Disord; 2002 Nov; 17(6):1242-7. PubMed ID: 12465063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pupillary autonomic dysfunction in multiple system atrophy and Parkinson's disease: an assessment by eye-drop tests.
    Yamashita F; Hirayama M; Nakamura T; Takamori M; Hori N; Uchida K; Hama T; Sobue G
    Clin Auton Res; 2010 Jun; 20(3):191-7. PubMed ID: 20127386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity and specificity of cardiac
    Kawazoe M; Arima H; Maeda T; Tsuji M; Mishima T; Fujioka S; Tsugawa J; Tsuboi Y
    J Neurol Sci; 2019 Dec; 407():116409. PubMed ID: 31706063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis.
    Orimo S; Suzuki M; Inaba A; Mizusawa H
    Parkinsonism Relat Disord; 2012 Jun; 18(5):494-500. PubMed ID: 22321865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
    PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy.
    Braune S; Reinhardt M; Schnitzer R; Riedel A; Lücking CH
    Neurology; 1999 Sep; 53(5):1020-5. PubMed ID: 10496261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine.
    Kimber JR; Watson L; Mathias CJ
    Lancet; 1997 Jun; 349(9069):1877-81. PubMed ID: 9217760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa challenge test and (123) I-metaiodobenzylguanidine scintigraphy for diagnosing Parkinson's disease.
    Asayama S; Wate R; Kaneko S; Asayama T; Oki M; Tsuge A; Nagashima M; Morita J; Nakamura S; Nakamura M; Nishii M; Fujita K; Saito A; Nakano S; Ito H; Kusaka H
    Acta Neurol Scand; 2013 Sep; 128(3):160-5. PubMed ID: 23410225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
    Saiki S; Hirose G; Sakai K; Kataoka S; Hori A; Saiki M; Kaito M; Higashi K; Taki S; Kakeshita K; Fujino S; Miaki M
    J Neurol Sci; 2004 May; 220(1-2):105-11. PubMed ID: 15140615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease?
    Tranchant C; Guiraud-Chaumeil C; Echaniz-Laguna A; Warter JM
    J Neurol; 2000 Nov; 247(11):853-6. PubMed ID: 11151417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease.
    Umemura A; Oeda T; Hayashi R; Tomita S; Kohsaka M; Yamamoto K; Sawada H
    PLoS One; 2013; 8(4):e61066. PubMed ID: 23613784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.